{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:51:08Z","timestamp":1776336668746,"version":"3.51.2"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Research Ward Excellence Program","award":["BRWEP2024W094090106"],"award-info":[{"award-number":["BRWEP2024W094090106"]}]},{"name":"Capital Health Development Research Special Project","award":["2024-1-409"],"award-info":[{"award-number":["2024-1-409"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-026-08923-7","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:52:49Z","timestamp":1773111169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of hydroxychloroquine on pregnancy outcomes in women with unexplained recurrent pregnancy loss complicated with antinuclear antibody positivity: a multicentre prospective cohort study protocol"],"prefix":"10.1186","volume":"26","author":[{"given":"Bin","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuejia","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuolin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guimin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"issue":"1","key":"8923_CR1","first-page":"hoad002","volume":"2023","author":"B EGGo","year":"2023","unstructured":"RPL, EGGo B, Atik R, Christiansen OB, Elson J, Kolte AM, Lewis S, et al. ESHRE guideline: recurrent pregnancy loss: an update in 2022. Hum Reprod Open. 2023;2023(1):hoad002.","journal-title":"Hum Reprod Open"},{"issue":"5","key":"8923_CR2","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","volume":"98","author":"Practice Committee of the American Society for Reproductive M","year":"2012","unstructured":"Practice Committee of the American Society for Reproductive M. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103\u201311.","journal-title":"Fertil Steril"},{"issue":"1","key":"8923_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41572-020-00228-z","volume":"6","author":"E Dimitriadis","year":"2020","unstructured":"Dimitriadis E, Menkhorst E, Saito S, Kutteh WH, Brosens JJ. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6(1):98.","journal-title":"Nat Rev Dis Primers"},{"key":"8923_CR4","doi-asserted-by":"publisher","first-page":"657552","DOI":"10.3389\/fimmu.2021.657552","volume":"12","author":"H Liu","year":"2021","unstructured":"Liu H, Lin XX, Huang XB, Huang DH, Song S, Chen YJ, et al. Systemic Characterization of Novel Immune Cell Phenotypes in Recurrent Pregnancy Loss. Front Immunol. 2021;12:657552.","journal-title":"Front Immunol"},{"key":"8923_CR5","doi-asserted-by":"publisher","first-page":"728291","DOI":"10.3389\/fimmu.2021.728291","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wei H. Role of Decidual Natural Killer Cells in Human Pregnancy and Related Pregnancy Complications. Front Immunol. 2021;12:728291.","journal-title":"Front Immunol"},{"issue":"1","key":"8923_CR6","doi-asserted-by":"publisher","first-page":"e13200","DOI":"10.1111\/aji.13200","volume":"83","author":"S D\u2019Ippolito","year":"2020","unstructured":"D\u2019Ippolito S, Ticconi C, Tersigni C, Garofalo S, Martino C, Lanzone A, et al. The pathogenic role of autoantibodies in recurrent pregnancy loss. Am J Reprod Immunol. 2020;83(1):e13200.","journal-title":"Am J Reprod Immunol"},{"issue":"6","key":"8923_CR7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/aji.12429","volume":"74","author":"M Veglia","year":"2015","unstructured":"Veglia M, D\u2019Ippolito S, Marana R, Di Nicuolo F, Castellani R, Bruno V, et al. Human IgG Antinuclear Antibodies Induce Pregnancy Loss in Mice by Increasing Immune Complex Deposition in Placental Tissue: In Vivo Study. Am J Reprod Immunol. 2015;74(6):542\u201352.","journal-title":"Am J Reprod Immunol"},{"issue":"4","key":"8923_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.semarthrit.2020.03.016","volume":"50","author":"S Chen","year":"2020","unstructured":"Chen S, Yang G, Wu P, Sun Y, Dai F, He Y, et al. Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis. Semin Arthritis Rheum. 2020;50(4):534\u201343.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"8923_CR9","doi-asserted-by":"publisher","first-page":"e13215","DOI":"10.1111\/aji.13215","volume":"83","author":"MB Cavalcante","year":"2020","unstructured":"Cavalcante MB, Cavalcante C, Sarno M, da Silva ACB, Barini R. Antinuclear antibodies and recurrent miscarriage: Systematic review and meta-analysis. Am J Reprod Immunol. 2020;83(3):e13215.","journal-title":"Am J Reprod Immunol"},{"key":"8923_CR10","doi-asserted-by":"publisher","first-page":"103794","DOI":"10.1016\/j.jri.2022.103794","volume":"155","author":"C Ticconi","year":"2023","unstructured":"Ticconi C, Inversetti A, Logruosso E, Ghio M, Casadei L, Selmi C, et al. Antinuclear antibodies positivity in women in reproductive age: From infertility to adverse obstetrical outcomes - A meta-analysis. J Reprod Immunol. 2023;155:103794.","journal-title":"J Reprod Immunol"},{"issue":"3","key":"8923_CR11","doi-asserted-by":"publisher","first-page":"e13158","DOI":"10.1111\/aji.13158","volume":"82","author":"M Zeng","year":"2019","unstructured":"Zeng M, Wen P, Duan J. Association of antinuclear antibody with clinical outcome of patients undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment: A meta-analysis. Am J Reprod Immunol. 2019;82(3):e13158.","journal-title":"Am J Reprod Immunol"},{"key":"8923_CR12","doi-asserted-by":"crossref","unstructured":"Yoshihara HGS, Kitaori T, Sugiura-Ogasawara M. Association between antinuclear antibodies and pregnancy prognosis in recurrent pregnancy loss patients. Hum Reprod. 2025;40(2):236\u2013243.","DOI":"10.1093\/humrep\/deae280"},{"issue":"10","key":"8923_CR13","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1093\/humrep\/15.10.2220","volume":"15","author":"RBM Rai","year":"2000","unstructured":"Rai RBM, Baxter N, Chilcott I, Regan L. Recurrent miscarriage\u2013an aspirin a day? Hum Reprod. 2000;15(10):2220\u20133.","journal-title":"Hum Reprod"},{"issue":"14","key":"8923_CR14","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1182\/blood-2014-11-610857","volume":"125","author":"E Pasquier","year":"2015","unstructured":"Pasquier E, de Saint Martin L, Bohec C, Chauleur C, Bretelle F, Marhic G, et al. Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial. Blood. 2015;125(14):2200\u20135.","journal-title":"Blood"},{"key":"8923_CR15","doi-asserted-by":"crossref","unstructured":"Kaandorp SPGM, van der Post JA, Hutten BA, Verhoeve HR, Hamulyak K, Mol BW, Folkeringa N, Nahuis M, PapatsonisDN, Buller HR, van der Veen F, Middeldorp S. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med. 2010;29(17):1586\u201396.","DOI":"10.1056\/NEJMoa1000641"},{"key":"8923_CR16","doi-asserted-by":"crossref","unstructured":"Lubbe WF, Palmer WSBSJ, Liggins GC. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet. 1983;1(8338):1361\u20133.","DOI":"10.1016\/S0140-6736(83)92141-4"},{"issue":"1","key":"8923_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/aji.12493","volume":"76","author":"A Mekinian","year":"2016","unstructured":"Mekinian A, Cohen J, Alijotas-Reig J, Carbillon L, Nicaise-Roland P, Kayem G, et al. Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation? Am J Reprod Immunol. 2016;76(1):8\u201328.","journal-title":"Am J Reprod Immunol"},{"issue":"7","key":"8923_CR18","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/jcpt.13629","volume":"47","author":"N Ma","year":"2022","unstructured":"Ma N, Qin R, Qin W, Liao M, Zhao Y, Hang F, et al. Oral immunosuppressants improve pregnancy outcomes in women with idiopathic recurrent miscarriage: A meta-analysis. J Clin Pharm Ther. 2022;47(7):870\u20138.","journal-title":"J Clin Pharm Ther"},{"key":"8923_CR19","doi-asserted-by":"crossref","unstructured":"Pregnancy outcome after. first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol. 2004;18(1):93\u2013101.","DOI":"10.1016\/j.reprotox.2003.10.007"},{"issue":"3","key":"8923_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier E, Dorner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020;16(3):155\u201366.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"8923_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.autrev.2014.08.040","volume":"14","author":"A Mekinian","year":"2015","unstructured":"Mekinian A, Costedoat-Chalumeau N, Masseau A, Tincani A, De Caroli S, Alijotas-Reig J, et al. Obstetrical APS: is there a place for hydroxychloroquine to improve the pregnancy outcome? Autoimmun Rev. 2015;14(1):23\u20139.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"8923_CR22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.autrev.2015.01.012","volume":"14","author":"A Mekinian","year":"2015","unstructured":"Mekinian A, Lazzaroni MG, Kuzenko A, Alijotas-Reig J, Ruffatti A, Levy P, et al. The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study. Autoimmun Rev. 2015;14(6):498\u2013502.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"8923_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/ijgo.13556","volume":"154","author":"S Sun","year":"2021","unstructured":"Sun S, Li C, Kou X, Chen C, Guo F, Zhao A. Association of prednisone and antinuclear antibodies with pregnancy outcomes in women with unexplained recurrent pregnancy loss. Int J Gynaecol Obstet. 2021;154(3):492\u20139.","journal-title":"Int J Gynaecol Obstet"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-08923-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-08923-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-08923-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T09:59:19Z","timestamp":1776333559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-08923-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8923"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-08923-7","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study will be conducted in accordance with the principles of the Declaration of Helsinki and relevant Good Clinical Practice (GCP) guidelines. Ethical approval has been obtained from Peking University Third Hospital Medical Science Research Ethics Committee (M20250133), as well as from the ethics committees of all participating centres. The study was registered with the Chinese Clinical Trial Register (ChiCTR2500105183), the registration date is 2025-06-30.Written informed consent will be obtained from all participants prior to any study-related procedures. Participants will be informed of their right to withdraw from the study at any time without any impact on their standard medical care. To ensure participant confidentiality, all collected data will be de-identified and stored securely on password-protected servers, accessible only to authorised research personnel. Personal identifiers will not be used in any dissemination materials.The findings of this study will be disseminated through peer-reviewed journals, national and international conferences, and academic forums. Additionally, summary results may be shared with participants and stakeholders upon study completion. The final dataset will be archived according to institutional policies and applicable regulations.Any substantial protocol amendments will be submitted for additional ethics review and communicated to all investigators and relevant parties.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"417"}}